Amicus Therapeutics Inc (FOLD)
10.04
+0.06
(+0.55%)
USD |
NASDAQ |
May 01, 13:16
Amicus Therapeutics Shares Outstanding: 295.38M for Feb. 13, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 13, 2024 | 295.38M |
December 31, 2023 | 293.59M |
October 25, 2023 | 293.25M |
October 05, 2023 | 293.13M |
October 02, 2023 | 290.67M |
September 30, 2023 | 290.67M |
July 26, 2023 | 287.12M |
June 30, 2023 | 286.99M |
April 27, 2023 | 284.58M |
April 14, 2023 | 283.34M |
April 12, 2023 | 283.34M |
March 31, 2023 | 283.30M |
February 13, 2023 | 282.71M |
December 31, 2022 | 281.11M |
October 25, 2022 | 280.95M |
September 30, 2022 | 280.89M |
July 27, 2022 | 280.50M |
June 30, 2022 | 280.46M |
April 27, 2022 | 280.16M |
April 14, 2022 | 280.15M |
March 31, 2022 | 280.13M |
February 23, 2022 | 280.04M |
February 15, 2022 | 280.03M |
December 31, 2021 | 278.91M |
October 27, 2021 | 278.64M |
Date | Value |
---|---|
September 30, 2021 | 278.59M |
September 29, 2021 | 270.73M |
September 27, 2021 | 267.29M |
July 27, 2021 | 266.56M |
June 30, 2021 | 266.53M |
April 26, 2021 | 266.06M |
April 19, 2021 | 266.06M |
April 15, 2021 | 266.02M |
March 31, 2021 | 266.01M |
February 19, 2021 | 264.32M |
December 31, 2020 | 262.06M |
October 26, 2020 | 260.59M |
September 30, 2020 | 259.60M |
July 27, 2020 | 258.79M |
June 30, 2020 | 258.22M |
April 27, 2020 | 257.66M |
April 16, 2020 | 257.53M |
April 13, 2020 | 257.51M |
March 31, 2020 | 257.45M |
February 19, 2020 | 257.24M |
December 31, 2019 | 255.42M |
October 31, 2019 | 254.81M |
September 30, 2019 | 254.77M |
July 30, 2019 | 254.63M |
July 08, 2019 | 255.00M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
230.70M
Minimum
May 20 2019
295.38M
Maximum
Feb 13 2024
270.15M
Average
266.92M
Median
Shares Outstanding Benchmarks
TG Therapeutics Inc | 154.42M |
Geron Corp | 546.06M |
Vanda Pharmaceuticals Inc | 57.54M |
Fate Therapeutics Inc | 99.24M |
Editas Medicine Inc | 81.81M |